Connecticut

On June 15, 2005, Connecticut became the third state in the United States to provide public funding for research using adult and embryonic stem cells. The first year alone the state received 70 research proposals, most of them from researchers at the [Page 314]University of Connecticut and Yale University. Soon, some of the top researchers in the country left other states to take positions at Connecticut’s universities. Already home to major pharmaceutical companies, in 2011 the state launched the Bioscience Connecticut initiative, a plan to spend $850 million to build the state’s biomedical industry.

The governor’s office announced that the Jackson Laboratory for Genomic Medicine, a billion-dollar personalized medicine laboratory, would be located on the campus of the University of Connecticut, Farmington. StemCONN, a biennial international ...